Morphosys announced that its AbD Serotec division has signed an agreement with the Moredun Research Institute and the University of Edinburgh's Roslin Institute to develop reagents for veterinary research.
The project is supported by a three-year Industrial Partnership Award from the UK's Biotechnology and Biological Sciences Research Council that will provide the Moredun and Roslin institutes with close to £1 million ($1.58 million). Its primary focus is to develop species-specific protein reagents for studying immunity in ruminant farm animals.